Search results

Interventional procedures, IPG454 - Issued: April 2013 --> This guidance has been updated and replaced by NICE interventional procedures guidance 603.

Result type

Interventional procedures guidance

Published

26 April 2013

Evidence-based recommendations on extracorporeal membrane oxygenation in postneonatal children. This involves connecting the child's internal circulation to an external blood pump and artificial lung.

Result type

Interventional procedures guidance

Published

28 January 2004

Evidence-based recommendations on cryotherapy for malignant endobronchial obstruction. This involves using cold temperatures to destroy the cancer tissue that’s causing a blockage.

Result type

Interventional procedures guidance

Published

23 November 2005

Evidence-based recommendations on teduglutide (Resvestive) for treating short bowel syndrome in people 1 year and above.

Result type

Technology appraisal guidance

Published

30 June 2022

Evidence-based recommendations on pegcetacoplan (Aspaveli) for treating paroxysmal nocturnal haemoglobinuria in adults who have anaemia after at least 3 months of treatment with a C5 inhibitor.

Result type

Technology appraisal guidance

Published

9 March 2022

Evidence-based recommendations on panobinostat (Farydak) for treating multiple myeloma after at least 2 previous treatments.

Result type

Technology appraisal guidance

Published

27 January 2016

Evidence-based recommendations on roxadustat (Evrenzo) for treating symptomatic anaemia associated with chronic kidney disease in adults.

Result type

Technology appraisal guidance

Published

13 July 2022

Evidence-based recommendations on atezolizumab (Tecentriq) with bevacizumab (Avastin), carboplatin and paclitaxel for metastatic non-squamous non-small-cell lung cancer in adults.

Result type

Technology appraisal guidance

Published

5 June 2019

Evidence-based recommendations on osimertinib (Tagrisso) with pemetrexed and platinum-based chemotherapy for untreated EGFR mutation-positive advanced non-small-cell lung cancer in adults.

Result type

Technology appraisal guidance

Published

8 May 2025

This guideline covers diagnosing and managing secondary cancer in people aged 18 and over when the site of the primary cancer is unknown. This includes people who have had treatment for cancer before. It aims to improve quality of life by offering advice on tests for identifying the site of the primary cancer and options for managing the person’s condition.

Result type

Clinical guideline

Last updated

26 April 2023

Evidence-based recommendations on deep brain stimulation for refractory chronic pain syndromes (excluding headache). This involves stimulating a precise area of the brain using an electrode to treat the chronic pain.

Result type

Interventional procedures guidance

Published

23 March 2011

Evidence-based recommendations on hybrid procedure for interim management of hypoplastic left heart syndrome in neonates. This involves placing bands around the branches of the pulmonary artery and inserting stents to keep the ductus arteriosus open.

Result type

Interventional procedures guidance

Published

12 December 2007

Evidence-based recommendations on birch bark extract (Filsuvez) for treating partial thickness wounds associated with dystrophic and junctional epidermolysis bullosa in people aged 6 months and over.

Result type

Highly specialised technologies guidance

Published

20 September 2023

Evidence-based recommendations on daratumumab (Darzalex) for relapsed and refractory multiple myeloma in adults.

Result type

Technology appraisal guidance

Published

13 April 2022

Evidence-based recommendations on ibrutinib (Imbruvica) for Waldenstrom’s macroglobulinaemia in adults who have had at least 1 previous therapy.

Result type

Technology appraisal guidance

Published

8 June 2022